Clinical Trials Browser

Phase 2 × Advanced Pancreatic Cancer × Taxes × Clear all

NCT05298020 2022-03-28

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

Phase 2 Unknown

Gastrointestinal

Advanced Pancreatic Cancer

NCT02124317 2016-12-22

NAPSPAC

Phase 2 Unknown

Gastrointestinal

Advanced Pancreatic Cancer

NCT02135822 2014-05-16

NAPGAP

Phase 2 Unknown

Gastrointestinal

Advanced Pancreatic Cancer